FDA Approved: CLOBAZAM — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved a supplemental application for CLOBAZAM (clobazam) from Amneal Pharmaceuticals NY LLC under the ANDA pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Lennox-gastaut Syndrome

Drugs mentioned

• CLOBAZAM (CLOBAZAM)

Snippet

SUPPL AP for CLOBAZAM (CLOBAZAM)